Detection of EGFR T790M in EGFR activating mutation-positive advanced non-small cell lung cancer (NSCLC): Comparison between two assays on circulating tumour (ct)DNA

被引：0
|
作者：
Charpentier, S. [1 ]
Herbreteau, G. [1 ]
Vallee, A. [1 ]
Henaff, D. [2 ]
Grewis, L. [2 ]
Denis, M. G. [3 ]
机构：
[1] CHU Nantes, Hotel Dieu, Biochim Plateforme Genet Canc, Nantes, France
[2] ID Solut, Grabels, France
[3] CHU Nantes, Hotel Dieu, Biochem Dept, Nantes, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1354P
引用
收藏
页码：S868 / S868
页数：1
相关论文
共 50 条
  • [21] Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer
    Berz D.
    Raymond V.M.
    Garst J.H.
    Erlander M.G.
    Experimental Hematology & Oncology, 5 (1)
  • [22] Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Kyeong Yeon
    Kim, Chi Young
    Lee, Sang Hoon
    Heo, Seok-Jae
    Chang, Yoon Soo
    Kim, Eun Young
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [23] Ultrasensitive detection of the pretreatment EGFR T790M mutation in non-small cell lung cancer patients with an EGFR-activating mutation using picodroplet digital PCR
    Koh, Yasuhiro
    Kawaguchi, Tomoya
    Watanabe, Masaru
    Isa, Shun-ichi
    Ando, Masahiko
    Tamiya, Akihiro
    Kubo, Akihito
    Saka, Hideo
    Takeo, Sadanori
    Adach, Hirofumi
    Tagawa, Tsutomu
    Kakegawa, Seiichi
    Yamashita, Motohiro
    Kataoka, Kazuhiko
    Ichinose, Yukito
    Takeuchi, Yukiyasu
    Sakamoto, Kazuhiro
    Matsumura, Akihide
    CANCER RESEARCH, 2015, 75
  • [24] Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer
    John, Thomas
    Bowden, Jeffrey J.
    Clarke, Stephen
    Fox, Stephen B.
    Garrett, Kerryn
    Horwood, Keith
    Karapetis, Christos S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (04) : 296 - 303
  • [25] Evidence-based best practices for EGFR and EGFR T790M mutation testing in non-small cell lung cancer (NSCLC) in the UK
    Welch, L.
    Butler, R.
    Taniere, P.
    Thompson, L.
    Oniscu, A.
    Clarke, C.
    Burghel, G.
    Collins, N.
    Timm, L.
    LUNG CANCER, 2019, 127 : S14 - S14
  • [26] Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status
    Nakashima, Kazuhisa
    Kimura, Madoka
    Akamatsu, Hiroaki
    Daga, Haruko
    Imai, Hisao
    Taira, Tetsuhiko
    Ko, Ryo
    Hisamatsu, Yasushi
    Nishino, Kazumi
    Sugimoto, Takeya
    Miyashita, Yosuke
    Takahashi, Toshiaki
    Kumagai, Toru
    Yamamoto, Nobuyuki
    Murakami, Haruyasu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (07) : 671 - 675
  • [27] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Nakashima, Kazuhisa
    Ozawa, Yuichi
    Daga, Haruko
    Imai, Hisao
    Tamiya, Motohiro
    Tokito, Takaaki
    Kawamura, Takahisa
    Akamatsu, Hiroaki
    Tsuboguchi, Yuko
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Mori, Keita
    Murakami, Haruyasu
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) : 1854 - 1861
  • [28] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Kazuhisa Nakashima
    Yuichi Ozawa
    Haruko Daga
    Hisao Imai
    Motohiro Tamiya
    Takaaki Tokito
    Takahisa Kawamura
    Hiroaki Akamatsu
    Yuko Tsuboguchi
    Toshiaki Takahashi
    Nobuyuki Yamamoto
    Keita Mori
    Haruyasu Murakami
    Investigational New Drugs, 2020, 38 : 1854 - 1861
  • [29] Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer
    Lin, Yi-Tsz
    Chu, Chia-Yu
    LUNG CANCER, 2019, 129 : 110 - 111
  • [30] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
12345